法律2026/09/25@LawDesk
Supreme Court Restores Mail Access to Mifepristone in Louisiana Case
Supreme Court of the United StatesSupreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United States
開始 2026/05/14確定確度 84%134 日前The order in Nos. 25A1207 and 25A1208 is dated "[May 14, 2026]" and says "The applications for stay ... are granted".^[1]
The Supreme Court stayed the Fifth Circuit's order in Louisiana v. FDA, so mifepristone can again be prescribed by telehealth and sent by mail while the case goes on; Justices Thomas and Alito dissented.
0.85
法律2026/09/25@LawDesk
Fifth Circuit Reinstates In-Person Dispensing for Mifepristone
United States Court of Appeals for the Fifth CircuitUnited States Court of Appeals Fifth Circuit, 600, Camp Street, Central Business District, French Quarter, New Orleans, Orleans Parish, Louisiana, 70130, United States
開始 2026/05/01確定確度 82%147 日前The opinion in No. 26-30203 is stamped "FILED May 1, 2026" and orders that "the motion to stay the 2023 REMS under 5 U.S.C. § 705 pending appeal is GRANTED".^[1]
A Fifth Circuit panel granted Louisiana a stay of the FDA's 2023 mifepristone rules, ending telehealth prescribing and mail or pharmacy dispensing of the abortion pill nationwide until the Supreme Court stepped in.
0.80
法律2026/09/25@LawDesk
Supreme Court Rejects Challenge to Mifepristone in FDA v. Alliance
Supreme Court of the United StatesSupreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United States
開始 2024/06/13確定確度 84%2.3 年前The slip opinion in No. 23-235 is headed "Argued March 26, 2024—Decided June 13, 2024".^[1]
A unanimous Supreme Court threw out anti-abortion doctors' challenge to the FDA's rules for the abortion pill mifepristone, holding they had no standing to sue, so mail and telehealth access stayed in place.
0.70
法律2026/09/25@LawDesk
Third Circuit Lists Arm's Appeal Against Qualcomm for October 20
James A. Byrne Courthouse, 601, Market Street, Old City, Center City, Philadelphia, Philadelphia County, Pennsylvania, 19106, United StatesQualcomm
開始 2026/10/20予定確度 80%25 日後The clerk's letter says the case 'has been tentatively listed on the merits for Tuesday, October 20, 2026, in PHILADELPHIA, PA' and may move 'to another day within the week of October 19, 2026'.^[1]
The US Court of Appeals for the Third Circuit has listed Arm's appeal of the Delaware judgment for Qualcomm and Nuvia on the merits in Philadelphia, with oral argument at the panel's discretion.
0.64
法律2026/09/25@LawDesk
Federal Circuit Hears ParkerVision's Appeal in Qualcomm Patent Case
Howard T. Markey National Courts Building, 717, Madison Place Northwest, Ward 2, Washington, District of Columbia, 20005, United StatesQualcomm
開始 2026/06/01 14:00確定確度 89%116 日前The Federal Circuit's notice says 'This case has been scheduled for oral argument on June 1, 2026 at 10:00 a.m.', and the court posted the argument's audio on 1 June 2026.^[1]
A Federal Circuit panel of Judges Prost, Chen and Stark heard ParkerVision's appeal of the claim construction that ended its receiver-patent claims against Qualcomm.
0.64
健康2026/09/25@HealthDesk
FDA Approves Evita Solutions' Generic Mifepristone
Evita SolutionsMahan Court, Federal Research Center, White Oak, Montgomery County, Maryland, 20993, United States
開始 2025/09/30 14:20確定確度 83%360 日前The ANDA 216616 approval letter says "the ANDA is approved, effective on the date of this letter" and is digitally signed "Date: 9/30/2025 10:20:02AM".^[1]
The FDA approved Evita Solutions' 200 mg mifepristone tablets as the second generic of the abortion pill, less than two weeks after HHS promised a safety review of the drug.
0.64
法律2026/09/25@LawDesk
Arm Appeals Its Loss to Qualcomm to the Third Circuit
J. Caleb Boggs Federal Building, 844, North King Street, Downtown, Wilmington, New Castle County, Delaware, 19801, United StatesArm Holdings
開始 2025/10/01確定確度 89%359 日前Arm's notice of appeal is filed 10/01/25 and signed 'Dated: October 1, 2025'.^[1]
Arm filed a notice of appeal to the US Court of Appeals for the Third Circuit a day after a Delaware judge entered final judgment for Qualcomm and Nuvia in its licence suit.
0.60
法律2026/09/25@LawDesk
Florida Court Enters Judgment for Qualcomm on ParkerVision Receiver Claims
401, West Central Boulevard, Callahan, Orlando, Orange County, Florida, 32801, United StatesQualcomm
開始 2025/10/02確定確度 86%358 日前The order granting the stipulated Rule 54(b) final judgment is 'Signed by Judge Paul G. Byron on 10/2/2025'; Qualcomm's 10-K says 'On October 2, 2025, the court entered a final judgment in our favor'.^[1]
Eleven years into ParkerVision's radio-chip patent suit, a federal judge in Orlando entered a stipulated final judgment that Qualcomm does not infringe its receiver patents and stayed the rest pending appeal.
0.59
法律2026/09/24@LawDesk
判事、ルイジ・マンジョーネ被告への死刑適用を排除
United States District Court for the Southern District of New YorkThurgood Marshall United States Courthouse, 40, Centre Street, Civic Center, Lower Manhattan, Manhattan, New York County, New York, 10007, United States
開始 2026/01/30確定確度 87%238 日前CNBC^[1]（2026年1月30日）によると、マンジョーネ被告は「死刑判決の可能性に直面しない」と判事が「金曜日に判断した」。意見・命令書には「日付：2026年1月30日」と署名されている。
連邦地裁のマーガレット・ガーネット判事は、ルイジ・マンジョーネ被告に対する連邦の銃器関連の訴因2件を棄却した。死刑の対象となる唯一の罪も含まれ、残るのは最高で終身刑となるストーカー行為の訴因2件となった。
0.59
法律2026/09/24@LawDesk
第1巡回区控訴裁、ハーバード大留学生問題の控訴審で弁論
Harvard UniversityMoakley US Courthouse, 1, Courthouse Way, Seaport, Boston, Suffolk County, Massachusetts, 02210, United States
開始 2026/10/06 19:00予定確度 79%11 日後2026年8月26日付の第1巡回区控訴裁判所の期日通知で予定として示されている：「2026年10月6日（火）午後3時の特別時刻に、マサチューセッツ州ボストンのモークリー連邦裁判所の大法廷用法廷で口頭弁論を行う予定」（米東部夏時間午後3時＝協定世界時19時）。^[1]
米第1巡回区控訴裁判所は、ハーバード大学の留学生受け入れを可能にしている差し止め命令に対するトランプ政権の控訴について、モークリー連邦裁判所の大法廷用法廷で弁論を開く。
0.59
法律2026/09/24@LawDesk
第2巡回区控訴裁、ショーン・“ディディ”・コムズ被告の量刑をめぐる控訴を審理
United States Court of Appeals for the Second CircuitThurgood Marshall United States Courthouse, 40, Centre Street, Civic Center, Lower Manhattan, Manhattan, New York County, New York, 10007, United States
開始 2026/04/09 14:00確定確度 85%169 日前裁判所の通知は弁論を「2026年4月9日午前10時、フォーリー・スクエア40番地」に設定しており（LA Mag^[3]）、Courthouse News^[1]はコムズ被告が「木曜日の朝」（2026年4月9日）に有罪判決の破棄を「連邦控訴裁判所に求めた」と報じている。
第2巡回区控訴裁判所の3人の判事による合議体は、禁錮50カ月の量刑が陪審が無罪とした行為に不当に依拠しているとするショーン・コムズ被告の控訴を審理し、2時間の弁論の後に判断を留保した。
0.59
法律2026/09/24@LawDesk
パリ検察、キンダーのサルモネラ菌問題でフェレロへの捜査を開始
Tribunal de Paris, Parvis Robert Badinter, 75017 Paris, FranceFerrero
開始 2022/05/25確定確度 90%4.3 年前ici^[1]（AFP、2022年6月9日）によると「この捜査は5月25日に開始された」。
パリ裁判所の公衆衛生部門は、アルロン産のキンダー製品をめぐるフードウォッチの告訴を受け、健康を危険にさらす加重詐欺、過失傷害、他人の生命を危険にさらした罪の疑いで予備捜査を開始した。
0.59

The court's recording of 26-30203 State of Louisiana v. FDA gives "Hearing Date: Wednesday, September 9, 2026 Courtroom: En Banc Courtroom".^[1]

開始: 2026年9月9日確度 90%出典：出典

Fifth Circuit Hears Louisiana's Appeal Against Mail-Order Mifepristone

A Fifth Circuit panel of Judges Richman, Higginson and Douglas heard Louisiana's bid to end telehealth prescribing of mifepristone and pressed the state hard on whether it has standing to sue.

The Fifth Circuit heard argument in State of Louisiana v. FDA (No. 26-30203) in its En Banc Courtroom before Judges Priscilla Richman, Stephen Higginson and Dana Douglas; counsel were Jorge Aguinaga, Daniel Winik, Jessica Ellsworth and John Elwood^[1]
Louisiana asked the court to stay the FDA's 2023 removal of the in-person dispensing requirement, saying 1,000 abortions a month in the state come from mailed mifepristone^[3]
Richman said she could not find anywhere in the record that the FDA approved mailing the drug into states where that is unlawful, and the judges cited the Supreme Court's 2024 standing ruling^[2]
The federal government argued Louisiana lacks standing and, alternatively, that the appeal should wait for FDA's own review^[2][5]
The Supreme Court's 14 May stay keeps mail access in place meanwhile, and FDA owes the district court a status report on its review by 7 October 2026^[5]

@LawDesk

参考資料 5確度 83%

最初の項目は常にピンの出典です。全体の確度は、各資料が上記の開始・終了時刻をどれだけ強く裏付けているかの加重平均です。最新の資料より180日古くなるごとに、重みは半分になります。

[1]90%
youtube.com/watch?v=y-xrEz6rtB0
youtube.com· 投稿 2026年9月25日· 開始 2026年9月9日 ✓· スコアの 23%
The court's recording of 26-30203 State of Louisiana v. FDA gives "Hearing Date: Wednesday, September 9, 2026 Courtroom: En Banc Courtroom".
[2]85%
Appeals court considers future of nationwide access to medication abortion (CNN)
cnn.com· 公開 2026年9月9日· スコアの 21%
Judge Richman told Louisiana Solicitor General Ben Aguiñaga she could not find in the record that FDA approved mailing the drug into states where it is unlawful; notes the panel's moderate-left lean and that the Justice Department argued standing alone was enough to reject the request.^[1]
[3]85%
Fifth Circuit questions Louisiana's renewed attempt to block abortion pill mailing (Courthouse News Service)
courthousenews.com· 公開 2026年9月9日· スコアの 21%
Aguiñaga: "There's no dispute that Louisiana's experiencing 1,000 abortions a month due to mifepristone mailed into the state"; Higginson questioned whether the panel could "stay the stay" given the Supreme Court's order.^[1]
[4]75%
Louisiana attorney general speaks outside 5th circuit after making arguments in abortion pill restriction case (WDSU News)
youtube.com· 公開 2026年9月9日· スコアの 21%
Attorney General Liz Murrill speaking outside the courthouse after the argument.^[1]
[5]80%
Louisiana v. FDA: Abortion Pill Access Under Fire (Center for Reproductive Rights)
reproductiverights.org· 公開 2026年5月7日· スコアの 13%
The Fifth Circuit granted Louisiana's motion to expedite on 23 June 2026 and set argument for 9 September; FDA must file a status report on its review in the district court by 7 October 2026.^[1]

修正を提案

足りない点や誤りがありますか？このピンを裏付けるリンク、別の開始日・終了日とその理由、欠けている情報や誤っている情報を、自由に書いてください。AIがこのピンの出典と照らし合わせ、より良い情報源を探し、裏付けとなるページがあれば参考資料として追加します。ピン自身の出典が引き続き最も重視されます。

スレッド

このピンに返信

法律2026/09/25@LawDesk
Supreme Court Restores Mail Access to Mifepristone in Louisiana Case
Supreme Court of the United StatesSupreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United States
開始 2026/05/14確定確度 84%134 日前The order in Nos. 25A1207 and 25A1208 is dated "[May 14, 2026]" and says "The applications for stay ... are granted".^[1]
The Supreme Court stayed the Fifth Circuit's order in Louisiana v. FDA, so mifepristone can again be prescribed by telehealth and sent by mail while the case goes on; Justices Thomas and Alito dissented.
0.85
法律2026/09/25@LawDesk
Fifth Circuit Reinstates In-Person Dispensing for Mifepristone
United States Court of Appeals for the Fifth CircuitUnited States Court of Appeals Fifth Circuit, 600, Camp Street, Central Business District, French Quarter, New Orleans, Orleans Parish, Louisiana, 70130, United States
開始 2026/05/01確定確度 82%147 日前The opinion in No. 26-30203 is stamped "FILED May 1, 2026" and orders that "the motion to stay the 2023 REMS under 5 U.S.C. § 705 pending appeal is GRANTED".^[1]
A Fifth Circuit panel granted Louisiana a stay of the FDA's 2023 mifepristone rules, ending telehealth prescribing and mail or pharmacy dispensing of the abortion pill nationwide until the Supreme Court stepped in.
0.80
法律2026/09/25@LawDesk
Supreme Court Rejects Challenge to Mifepristone in FDA v. Alliance
Supreme Court of the United StatesSupreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United States
開始 2024/06/13確定確度 84%2.3 年前The slip opinion in No. 23-235 is headed "Argued March 26, 2024—Decided June 13, 2024".^[1]
A unanimous Supreme Court threw out anti-abortion doctors' challenge to the FDA's rules for the abortion pill mifepristone, holding they had no standing to sue, so mail and telehealth access stayed in place.
0.70
法律2026/09/25@LawDesk
Third Circuit Lists Arm's Appeal Against Qualcomm for October 20
James A. Byrne Courthouse, 601, Market Street, Old City, Center City, Philadelphia, Philadelphia County, Pennsylvania, 19106, United StatesQualcomm
開始 2026/10/20予定確度 80%25 日後The clerk's letter says the case 'has been tentatively listed on the merits for Tuesday, October 20, 2026, in PHILADELPHIA, PA' and may move 'to another day within the week of October 19, 2026'.^[1]
The US Court of Appeals for the Third Circuit has listed Arm's appeal of the Delaware judgment for Qualcomm and Nuvia on the merits in Philadelphia, with oral argument at the panel's discretion.
0.64
法律2026/09/25@LawDesk
Federal Circuit Hears ParkerVision's Appeal in Qualcomm Patent Case
Howard T. Markey National Courts Building, 717, Madison Place Northwest, Ward 2, Washington, District of Columbia, 20005, United StatesQualcomm
開始 2026/06/01 14:00確定確度 89%116 日前The Federal Circuit's notice says 'This case has been scheduled for oral argument on June 1, 2026 at 10:00 a.m.', and the court posted the argument's audio on 1 June 2026.^[1]
A Federal Circuit panel of Judges Prost, Chen and Stark heard ParkerVision's appeal of the claim construction that ended its receiver-patent claims against Qualcomm.
0.64
健康2026/09/25@HealthDesk
FDA Approves Evita Solutions' Generic Mifepristone
Evita SolutionsMahan Court, Federal Research Center, White Oak, Montgomery County, Maryland, 20993, United States
開始 2025/09/30 14:20確定確度 83%360 日前The ANDA 216616 approval letter says "the ANDA is approved, effective on the date of this letter" and is digitally signed "Date: 9/30/2025 10:20:02AM".^[1]
The FDA approved Evita Solutions' 200 mg mifepristone tablets as the second generic of the abortion pill, less than two weeks after HHS promised a safety review of the drug.
0.64
法律2026/09/25@LawDesk
Arm Appeals Its Loss to Qualcomm to the Third Circuit
J. Caleb Boggs Federal Building, 844, North King Street, Downtown, Wilmington, New Castle County, Delaware, 19801, United StatesArm Holdings
開始 2025/10/01確定確度 89%359 日前Arm's notice of appeal is filed 10/01/25 and signed 'Dated: October 1, 2025'.^[1]
Arm filed a notice of appeal to the US Court of Appeals for the Third Circuit a day after a Delaware judge entered final judgment for Qualcomm and Nuvia in its licence suit.
0.60
法律2026/09/25@LawDesk
Florida Court Enters Judgment for Qualcomm on ParkerVision Receiver Claims
401, West Central Boulevard, Callahan, Orlando, Orange County, Florida, 32801, United StatesQualcomm
開始 2025/10/02確定確度 86%358 日前The order granting the stipulated Rule 54(b) final judgment is 'Signed by Judge Paul G. Byron on 10/2/2025'; Qualcomm's 10-K says 'On October 2, 2025, the court entered a final judgment in our favor'.^[1]
Eleven years into ParkerVision's radio-chip patent suit, a federal judge in Orlando entered a stipulated final judgment that Qualcomm does not infringe its receiver patents and stayed the rest pending appeal.
0.59
法律2026/09/24@LawDesk
判事、ルイジ・マンジョーネ被告への死刑適用を排除
United States District Court for the Southern District of New YorkThurgood Marshall United States Courthouse, 40, Centre Street, Civic Center, Lower Manhattan, Manhattan, New York County, New York, 10007, United States
開始 2026/01/30確定確度 87%238 日前CNBC^[1]（2026年1月30日）によると、マンジョーネ被告は「死刑判決の可能性に直面しない」と判事が「金曜日に判断した」。意見・命令書には「日付：2026年1月30日」と署名されている。
連邦地裁のマーガレット・ガーネット判事は、ルイジ・マンジョーネ被告に対する連邦の銃器関連の訴因2件を棄却した。死刑の対象となる唯一の罪も含まれ、残るのは最高で終身刑となるストーカー行為の訴因2件となった。
0.59
法律2026/09/24@LawDesk
第1巡回区控訴裁、ハーバード大留学生問題の控訴審で弁論
Harvard UniversityMoakley US Courthouse, 1, Courthouse Way, Seaport, Boston, Suffolk County, Massachusetts, 02210, United States
開始 2026/10/06 19:00予定確度 79%11 日後2026年8月26日付の第1巡回区控訴裁判所の期日通知で予定として示されている：「2026年10月6日（火）午後3時の特別時刻に、マサチューセッツ州ボストンのモークリー連邦裁判所の大法廷用法廷で口頭弁論を行う予定」（米東部夏時間午後3時＝協定世界時19時）。^[1]
米第1巡回区控訴裁判所は、ハーバード大学の留学生受け入れを可能にしている差し止め命令に対するトランプ政権の控訴について、モークリー連邦裁判所の大法廷用法廷で弁論を開く。
0.59
法律2026/09/24@LawDesk
第2巡回区控訴裁、ショーン・“ディディ”・コムズ被告の量刑をめぐる控訴を審理
United States Court of Appeals for the Second CircuitThurgood Marshall United States Courthouse, 40, Centre Street, Civic Center, Lower Manhattan, Manhattan, New York County, New York, 10007, United States
開始 2026/04/09 14:00確定確度 85%169 日前裁判所の通知は弁論を「2026年4月9日午前10時、フォーリー・スクエア40番地」に設定しており（LA Mag^[3]）、Courthouse News^[1]はコムズ被告が「木曜日の朝」（2026年4月9日）に有罪判決の破棄を「連邦控訴裁判所に求めた」と報じている。
第2巡回区控訴裁判所の3人の判事による合議体は、禁錮50カ月の量刑が陪審が無罪とした行為に不当に依拠しているとするショーン・コムズ被告の控訴を審理し、2時間の弁論の後に判断を留保した。
0.59
法律2026/09/24@LawDesk
パリ検察、キンダーのサルモネラ菌問題でフェレロへの捜査を開始
Tribunal de Paris, Parvis Robert Badinter, 75017 Paris, FranceFerrero
開始 2022/05/25確定確度 90%4.3 年前ici^[1]（AFP、2022年6月9日）によると「この捜査は5月25日に開始された」。
パリ裁判所の公衆衛生部門は、アルロン産のキンダー製品をめぐるフードウォッチの告訴を受け、健康を危険にさらす加重詐欺、過失傷害、他人の生命を危険にさらした罪の疑いで予備捜査を開始した。
0.59

似たピン

参考資料 5確度 83%

修正を提案

コメント

スレッド

似たピン